Drugs in MeSH Category Antineoplastic Agents, Hormonal
✉ Email this page to a colleague
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Corepharma | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 218372-007 | Sep 17, 2024 | AB | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
Bausch | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 040700-001 | Aug 15, 2008 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Merck | DECADRON | dexamethasone | TABLET;ORAL | 011664-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Chiesi | MYCAPSSA | octreotide acetate | CAPSULE, DELAYED RELEASE;ORAL | 208232-001 | Jun 26, 2020 | RX | Yes | Yes | 10,238,709 | ⤷ Try for Free | ⤷ Try for Free | ||||
Novartis | SANDOSTATIN | octreotide acetate | INJECTABLE;INJECTION | 019667-005 | Jun 12, 1991 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Antineoplastic Agents, Hormonal Market Analysis and Financial Projection
More… ↓